Efficacy of rotational field TMS in major depressive disorder – A pilot study

Autor: Shmuel Hess, Maor Yeshua, Ami Eisen, Yuri Burnishev, Elsa Sultan, Gaby Pell, Colleen A. Hanlon, Abraham Weizman, Abraham Zangen, Yiftach Roth, Elisha Moses, Dror Weiss

Publikováno v: Brain Stimulation, Vol 17, Iss 4, Pp 907-910 (2024)

Externí odkaz: https://doaj.org/article/98ee13d523ce41e8aadf0150f6c0f31c

Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Autor: Amir Krivoy, Roy Onn, Yael Vilner, Eldar Hochman, Shira Weizman, Amir Paz, Shmuel Hess, Roi Sagy, Shiri Kimhi-Nesher, Ehud Kalter, Tal Friedman, Zvi Friedman, Gil Bormant, Sharon Trommer, Avi Valevski, Abraham Weizman

Publikováno v: EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)

Background: While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vita

Externí odkaz: https://doaj.org/article/944143d687cd49e69af5499f4226db81

[PREVALENCE OF TOBACCO SMOKING AMONG MENTAL HEALTH INPATIENTS IN ISRAEL]

Autor: Shmuel, Hess, Amir, Krivoy, Yael, Bar-Zeev, Afik, Faerman

Publikováno v: Harefuah. 160(2)

Tobacco smoking is the worldwide leading preventable cause of morbidity [1]. The prevalence of current smoking among individuals with mental illnesses is more than twice as that of the general population [2]. Despite it being a primary cause of morbi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::13765a2c3a40a429a2896a789534ec19
https://pubmed.ncbi.nlm.nih.gov/33760411

Phase-Amplitude Markers of Synchrony and Noise: A Resting-State and TMS-EEG Study of Schizophrenia

Autor: Alexander Grinshpoon, Nava Levit-Binnun, Jodie Naim-Feil, Shmuel Hess, Abraham Peled, Elisha Moses, Dominik Freche

Publikováno v: Cerebral Cortex Communications

The electroencephalogram (EEG) of schizophrenia patients is known to exhibit a reduction of signal-to-noise ratio and of phase locking, as well as a facilitation of excitability, in response to a variety of external stimuli. Here, we demonstrate thes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ead6eb84f3814a854f255f18cb3d92
https://pubmed.ncbi.nlm.nih.gov/34296092

Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Autor: Zvi Friedman, Shira Weizman, Sharon Trommer, Yael Vilner, Eldar Hochman, Ehud Kalter, Avi Valevski, Abraham Weizman, Roy Onn, Amir Krivoy, Tal Friedman, Shmuel Hess, Shiri Kimhi-Nesher, Gil Bormant, Roi Sagy, Amir Paz

Publikováno v: EBioMedicine
EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)
Krivoy, A, Onn, R, Vilner, Y, Hochman, E, Weizman, S, Paz, A, Hess, S, Sagy, R, Kimhi-Nesher, S, Kalter, E, Friedman, T, Friedman, Z, Bormant, G, Trommer, S, Valevski, A & Weizman, A 2017, ' Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine : A Randomized, Double-Blind, Placebo-controlled Clinical Trial ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2017.11.027

Background While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vitam

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::febe844cacd9a0510b917e5cf17f1189
http://europepmc.org/articles/PMC5832639